在IBD小鼠模型中增强性结肠炎期间,细菌群体对氨基酸可用性的限制
Tanner G Richie1, Leah Heeren1, Abigail Kamke1
1Division of Biology, Kansas State University, Manhattan, Kansas, USA.
mSystems
|November 1, 2023
概括
某些肠道细菌,如Enterobacteriaceae和Enterococcus,可能会通过使用硫代谢和宿主营养物质引起炎症性肠道疾病. 这促使它们在炎症的肠道中过度生长.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 与肠道中肠杆菌和肠球菌种类的增加有关.
- 这些细菌导致肠道炎症的确切机制尚不清楚.
- 现有的研究表明,肠道微生物群组成和炎症过程之间存在联系.
研究的目的:
- 研究细菌群体利用的特定途径来驱动IBD中的肠道炎症.
- 了解某些细菌,如Enterobacteriaceae和Enterococcus,如何促进炎症环境.
- 为了探索这些细菌的代谢能力在一个失生结肠的背景下.
主要方法:
- 对与炎症性肠病相关的细菌群体的分析.
- 对细菌硫代谢途径的研究.
- 评估细菌对宿主衍生的免疫产品的耐受性.
- 从异生物小鼠模型中培养细菌分离物.
- 用L-氨酸补充培养,以评估营养利用率.
主要成果:
- 特定的细菌群体采用替代硫代谢.
- 这些细菌对宿主衍生的免疫反应产物表现出耐受性.
- 已识别的代谢途径有助于宿主肠道炎症.
- 这些途径促进了病原生物在失生结肠中的过度殖民.
- 细菌分离物体在补充L-氨酸时显示增长,这表明宿主营养的利用.
结论:
- 替代硫代谢和对宿主免疫产品的耐受性是导致肠道炎症的关键机制,其中Enterobacteriaceae和Enterococcus物种驱动肠道炎症.
- 这些代谢策略使得病原生物在失生结肠中的过度生长成为可能.
- 能够利用L-氨酸等宿主营养素的能力支持这些细菌在炎症性肠病中的殖民和繁殖.
更多相关视频
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
854
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
19.6K
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Drugs for Treatment of Ulcerative Colitis in IBD
146
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
146
